Opioid-induced constipation. (Q54262333): Difference between revisions

From Wikidata

Jump to navigation Jump to search

Browse history interactively

← Older edit Newer edit →

Revision as of 08:13, 8 March 2019

scientific article

Language	Label	Description	Also known as
English	Opioid-induced constipation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

Opioid-induced constipation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

author name string

Naomi Hayashi

2

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

Hiroaki Tsukuura

3

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

Kazunori Honda

4

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

Tomoya Shimokata

5

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

Yuichi Ando

6

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

publication date

10 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

Scandinavian Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

50

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

11

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

1331-1338

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

Opioid-induced bowel dysfunction: pathophysiology and potential new therapies

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Function of opioids in the enteric nervous system

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Endogenous morphine.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Incidence, prevalence, and management of opioid bowel dysfunction

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1).

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

The narcotic bowel syndrome: clinical features, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Constipation in cancer patients on morphine

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Methylnaltrexone for opioid-induced constipation in advanced illness

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Opioid-induced constipation: challenges and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Differences in the prevalence and severity of side effects based on type of analgesic prescription in patients with chronic cancer pain

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Opioids and the gut: pharmacology and current clinical experience.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

The central and peripheral influences of opioids on gastrointestinal propulsion

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Meeting the challenges of opioid-induced constipation in chronic pain management - a novel approach

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Current and future therapies for chronic constipation

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Treatment of opioid-induced constipation with oral naloxone: A pilot study

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Alvimopan for postoperative ileus

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

A randomized, placebo-controlled phase 3 trial (Study SB-767905/012) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Methylnaltrexone and gastrointestinal perforation

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Naloxegol for opioid-induced constipation in patients with noncancer pain

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon?

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Mu-opioid and noradrenergic α(2)-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats.

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled pha

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Efficacy and safety of oral tapentadol extended release in Japanese and Korean patients with moderate to severe, chronic malignant tumor-related pain

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Oral naloxone reverses opioid-associated constipation

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Two randomized trials of linaclotide for chronic constipation

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Lubiprostone: a chloride channel activator

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Long‐term cancer pain management in morphine pre‐treated and opioid naive patients with transdermal fentanyl

1 reference

https://api.crossref.org/works/10.3109%2F00365521.2015.1054423

21 January 2018

Identifiers

10.3109/00365521.2015.1054423

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 May 2018

http://europepmc.org/abstract/MED/26061717

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54262333&oldid=877232396"